Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for toll-like receptors (TLR) 7 and 9

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Lenert, Petar S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHLOROQUINE; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 6; OLIGONUCLEOTIDE; POLYMYXIN; STAT PROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; ARTHRITIS; AUTOINFLAMMATORY DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOCYTOSIS; ENDOSOME; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHRITIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SILICOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UVEITIS; ANIMAL; CLASSIFICATION; CPG ISLAND; DRUG ANTAGONISM; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; TELOMERE;

ANIMALIA; BACTERIA (MICROORGANISMS); RNA VIRUSES;

ANIMALS; BASE SEQUENCE; CPG ISLANDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OLIGONUCLEOTIDES; TELOMERE; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 77953532645     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/986596     Document Type: Review

References (113)

1. Messina J. P., Gilkeson G. S., Pisetsky D. S., Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA Journal of Immunology 1991 147 6 1759 1764
2. Krieg A. M., Yi A.-K., Matson S., CpG motifs in bacterial DNA trigger direct B-cell activation Nature 1995 374 6522 546 549
3. Krieg A. M., CpG motifs in bacterial DNA and their immune effects Annual Review of Immunology 2002 20 709 760
4. Tokunaga T., Yamamoto H., Shimada S., Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity Journal of the National Cancer Institute 1984 72 4 955 962
5. Yamamoto S., Yamamoto T., Kataoka T., Kuramoto E., Yano O., Tokunaga T., Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity Journal of Immunology 1992 148 12 4072 4076
6. Hemmi H., Takeuchi O., Kawai T., A toll-like receptor recognizes bacterial DNA Nature 2000 408 6813 740 745
7. Bauer S., Kirschning C. J., Hacker H., Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition Proceedings of the National Academy of Sciences of the United States of America 2001 98 16 9237 9242
8. Haas T., Metzger J., Schmitz F., The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation Immunity 2008 28 3 315 323
9. Spies B., Hochrein H., Vabulas M., Wagner H: vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice Journal of Immunology 2003 171 11 5908 5912
10. Yasuda K., Yu P., Kirschning C. J., Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways Journal of Immunology 2005 174 10 6129 6136
11. Stetson D. B., Medzhitov R., Recognition of cytosolic DNA activates an IRF3-dependent innate immune response Immunity 2006 24 1 93 103
12. Cortez-Gonzalez X., Pellicciotta I., Gerloni M., TLR9-independent activation of B lymphocytes by bacterial DNA DNA and Cell Biology 2006 25 5 253 261
13. Wagner H., Bauer S., All is not Toll: new pathways in DNA recognition The Journal of Experimental Medicine 2006 203 2 265 268
14. Takaoka A., Wang Z., Choi M. K., DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response Nature 2007 448 7152 501 505
15. Roberts T. L., Idris A., Dunn J. A., HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA Science 2009 323 5917 1057 1060
16. Hornung V., Rothenfusser S., Britsch S., Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides Journal of Immunology 2002 168 9 4531 4537
17. Stacey K. J., Sweet M. J., Hume D. A., Macrophages ingest and are activated by bacterial DNA Journal of Immunology 1996 157 5 2116 2122
18. Zarember K. A., Godowski P. J., Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines Journal of Immunology 2002 168 2 554 561
19. Yi A.-K., Chang M., Peckham D. W., Krieg A. M., Ashman R. F., CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry Journal of Immunology 1998 161 2223 2231
20. Brummel R., Lenert P., Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides Journal of Immunology 2005 174 4 2429 2434 (Pubitemid 40223993)
21. Lenert P., Brummel R., Field E. H., Ashman R. F., TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production Journal of Clinical Immunology 2005 25 1 29 40
22. Sparwasser T., Koch E.-S., Vabulas R. M., Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells European Journal of Immunology 1998 28 6 2045 2054
23. Ronnblom L., Alm G. V., An etiopathogenic role for the type I IFN system in SLE Trends in Immunology 2001 22 8 427 431
24. Crow M. K., Kirou K. A., Interferon-alpha in systemic lupus erythematosus Current Opinion in Rheumatology 2004 16 5 541 547
25. Vallin H., Perers A., Alm G. V., Rnnblom L., Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN- inducer in systemic lupus erythematosus Journal of Immunology 1999 163 11 6306 6313
26. Bve U., Nordmark G., Lvgren T., Activation of the type I interferon system in primary Sjgren's syndrome: a possible etiopathogenic mechanism Arthritis and Rheumatism 2005 52 4 1185 1195
27. Herlands R. A., Christensen S. R., Sweet R. A., Hershberg U., Shlomchik M. J., T cell-independent and Toll-like receptor-dependent antigen-driven activation of autoreactive B cells Immunity 2008 29 2 249 260
28. Christensen S. R., Shupe J., Nickerson K., Kashgarian M., Flavell R. A., Shlomchik M. J., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus Immunity 2006 25 3 417 428
29. Wu X., Peng S. L., Toll-like receptor 9 signaling protects against murine lupus Arthritis and Rheumatism 2006 54 1 336 342
30. Hacker H., Mischak H., Miethke T., CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation EMBO Journal 1998 17 21 6230 6240
31. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R. M., Wagner H., Bacterial CpG-DNA and lipopolysaccharides activate toll-like receptors at distinct cellular compartments European Journal of Immunology 2002 32 7 1958 1968
32. Macfarlane D. E., Manzel L., Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds Journal of Immunology 1998 160 3 1122 1131
33. Lande R., Gregorio J., Facchinetti V., Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide Nature 2007 449 7162 564 569
34. Latz E., Schoenemeyer A., Visintin A., TLR9 signals after translocating from the ER to CpG DNA in the lysosome Nature Immunology 2004 5 2 190 198
35. Kim Y.-M., Brinkmann M. M., Paquet M.-E., Ploegh H. L., UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes Nature 2008 452 7184 234 238
36. Kono D. H., Haraldsson M. K., Lawson B. R., Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus Proceedings of the National Academy of Sciences of the United States of America 2009 106 29 12061 12066
37. Tabeta K., Hoebe K., Janssen E. M., The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 Nature Immunology 2006 7 2 156 164
38. Ewald S. E., Lee B. L., Lau L., The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor Nature 2008 456 7222 658 662
39. Sepulveda F. E., Maschalidi S., Colisson R., Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells Immunity 2009 31 5 737 748
40. Latz E., Verma A., Visintin A., Ligand-induced conformational changes allosterically activate Toll-like receptor 9 Nature Immunology 2007 8 7 772 779
41. Medzhitov R., Preston-Hurlburt P., Kopp E., MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways Molecular Cell 1998 2 2 253 258
42. Hacker H., Vabulas R. M., Takeuchi O., Hoshino K., Akira S., Wagner H., Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6 Journal of Experimental Medicine 2000 192 4 595 600
43. Muzio M., Natoli G., Saccani S., Levrero M., Mantovani A., The human toll signaling pathway: divergence of nuclear factor b and jnk/sapk activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) Journal of Experimental Medicine 1998 187 12 2097 2101
44. Wagner H., The immunobiology of the TLR9 subfamily Trends in Immunology 2004 25 7 381 386
45. Guiducci C., Ghirelli C., Marloie-Provost M.-A., PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation Journal of Experimental Medicine 2008 205 2 315 322
46. Kerkmann M., Rothenfusser S., Hornung V., Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells Journal of Immunology 2003 170 9 4465 4474
47. Halpern M. D., Pisetsky D. S., In vitro inhibition of murine IFN production by phosphorothioate deoxyguanosine oligomers Immunopharmacology 1995 29 1 47 52
48. Pisetsky D. S., Reich C. F., Inhibition of murine macrophage IL-12 production by natural and synthetic DNA Clinical Immunology 2000 96 3 198 204
49. Zhu F.-G., Reich C. F., Pisetsky D. S., Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides Journal of Leukocyte Biology 2002 72 6 1154 1163
50. Jing N., Li Y., Xu X., Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells DNA and Cell Biology 2003 22 11 685 696
51. Jing N., Li Y., Xiong W., Sha W., Jing L., Tweardy D. J., G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis Cancer Research 2004 64 18 6603 6609
52. Krieg A. M., Wu T., Weeratna R., Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs Proceedings of the National Academy of Sciences of the United States of America 1998 95 21 12631 12636
53. Chen Y., Lenert P., Weeratna R., Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs Gene Therapy 2001 8 13 1024 1032
54. Lenert P., Rasmussen W., Ashman R. F., Ballas Z. K., Structural characterization of the inhibitory DNA motif for the type A[D]-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells DNA and Cell Biology 2003 22 10 621 631
55. Ashman R. F., Goeken J. A., Drahos J., Lenert P., Sequence requirements for oligodeoxyribonucleotide inhibitory activity International Immunology 2005 17 4 411 420
56. Ho P. P., Fontoura P., Ruiz P. J., Steinman L., Garren H., An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems Journal of Immunology 2003 171 9 4920 4926
57. Graham K. L., Lee L. Y., Higgins J. P., Steinman L., Utz P. J., Ho P. P., Treatment with a Toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice Autoimmunity 2010 43 2 140 155
58. Lenert P., Stunz L., Yi A.-K., Krieg A. M., Ashman R. F., CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF- B activation Antisense and Nucleic Acid Drug Development 2001 11 4 247 256
59. Stunz L. L., Lenert P., Peckham D., Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells European Journal of Immunology 2002 32 5 1212 1222
60. Lenert P., Yi A.-K., Krieg A. M., Stunz L. L., Ashman R. F., Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells Oligonucleotides 2003 13 3 143 150
61. Gursel I., Gursel M., Yamada H., Ishii K. J., Takeshita F., Klinman D. M., Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation Journal of Immunology 2003 171 3 1393 1400
62. Lenert P., Yasuda K., Busconi L., DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fa slpr/lpr mice in vivo Arthritis Research and Therapy 2009 11 3, article R79
63. Lenert P., Inhibitory oligodeoxynucleotidestherapeutic promise for systemic autoimmune diseases? Clinical and Experimental Immunology 2005 140 1 1 10
64. Duramad O., Fearon K. L., Chang B., Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation Journal of Immunology 2005 174 9 5193 5200
65. Ashman R. F., Lenert P., Structural requirements and applications of inhibitory oligodeoxyribonucleotides Immunologic Research 2007 39 13 4 14
66. Haas T., Metzger J., Schmitz F., The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation Immunity 2008 28 3 315 323
67. Patole P. S., Zecher D., Pawar R. D., Grone H.-J., Schlondorff D., Anders H.-J., G-rich DNA suppresses systemic lupus Journal of the American Society of Nephrology 2005 16 11 3273 3280
68. Stacey K. J., Young G. R., Clark F., The molecular basis for the lack of immunostimulatory activity of vertebrate DNA Journal of Immunology 2003 170 7 3614 3620
69. Rutz M., Metzger J., Gellert T., Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner European Journal of Immunology 2004 34 9 2541 2550
70. Cornelie S., Hoebeke J., Schacht A.-M., Direct evidence that Toll-like Receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition Journal of Biological Chemistry 2004 279 15 15124 15129
71. Barrat F. J., Meeker T., Gregorio J., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus Journal of Experimental Medicine 2005 202 8 1131 1139
72. Peter M., Bode K., Lipford G. B., Eberle F., Heeg K., Dalpke A. H., Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity Immunology 2008 123 1 118 128
73. Pearson A. M., Rich A., Krieger M., Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices Journal of Biological Chemistry 1993 268 5 3546 3554
74. Trieu A., Bokil N., Dunn J. A., TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium Immunology and Cell Biology 2009 87 3 218 225
75. Lenert P. S., Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus Arthritis Research and Therapy 2006 8 1, article R203
76. Honda K., Ohba Y., Yanai H., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction Nature 2005 434 7036 1035 1040
77. Guiducci C., Ott G., Chan J. H., Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation Journal of Experimental Medicine 2006 203 8 1999 2008
78. Avalos A. M., Latz E., Mousseau B., Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides Journal of Immunology 2009 183 8 6262 6268
79. Verthelyi D., Ishii K. J., Gursel M., Takeshita F., Klinman D. M., Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs Journal of Immunology 2001 166 4 2372 2377
80. Krug A., Rothenfusser S., Hornung V., Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmocytoid dendritic cells European Journal of Immunology 2001 31 7 2154 2163
81. Kerkmann M., Costa L. T., Richter C., Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon- induction by CpG-A in plasmacytoid dendritic cells Journal of Biological Chemistry 2005 280 9 8086 8093
82. Bernasconi N. L., Onai N., Lanzavecchia A., A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in nave B cells and constitutive expression in memory B cells Blood 2003 102 11 956 63
83. Ruprecht C. R., Lanzavecchia A., Toll-like receptor stimulation as a third signal required for activation of human naive B cells European Journal of Immunology 2006 36 4 810 816
84. Brummel R., Roberts T. L., Stacey K. J., Lenert P., Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice European Journal of Immunology 2006 36 7 1951 1962
85. Poeck H., Wagner M., Battiany J., Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help Blood 2004 103 8 3058 3064
86. Busconi L., Bauer J. W., Tumang J. R., Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9 Journal of Immunology 2007 179 11 7397 7405
87. Hannum L. G., Ni D., Haberman A. M., Weigert M. G., Shlomchik M. J., A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease Journal of Experimental Medicine 1996 184 4 1269 1278
88. Leadbetter E. A., Rifkin I. R., Hohlbaum A. M., Beaudette B. C., Shlomchik M. J., Marshak-Rothstein A., Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors Nature 2002 416 6881 603 607
89. Lau C. M., Broughton C., Tabor A. S., RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement Journal of Experimental Medicine 2005 202 9 1171 1177
90. Peng S. L., Moslehi J., Craft J., Roles of interferon-gamma and interleukin-4 in murine lupus Journal of Clinical Investigation 1997 99 8 1936 1946
91. Haas C., Ryffel B., Le Hir M., IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice Journal of Immunology 1997 158 11 5484 5491
92. Hron J. D., Peng S. L., Type I IFN protects against murine lupus Journal of Immunology 2004 173 3 2134 2142
93. Blasco M. A., Gasser S. M., Lingner J., Telomeres and telomerase Genes and Development 1999 13 18 2353 2359
94. Klinman D. M., Tross D., Klaschik S., Shirota H., Sato T., Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides Annals of the New York Academy of Sciences 2009 1175 80 88
95. Shirota H., Gursel M., Klinman D. M., Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma and IL-12-mediated signaling Journal of Immunology 2004 173 8 5002 5007
96. Balasubramanian V., Nguyen L. T., Balasubramanian S. V., Ramanathan M., Interferon-gamma-inhibitory oligodeoxynucleotides alter the conformation of interferon-gamma Molecular Pharmacology 1998 53 5 926 932
97. Zeuner R. A., Verthelyi D., Gursel M., Ishii K. J., Klinman D. M., Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis Arthritis and Rheumatism 2003 48 6 1701 1707
98. Dong L., Ito S., Ishii K. J., Klinman D. M., Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice Arthritis and Rheumatism 2005 52 2 651 658
99. Sato T., Shimosato T., Alvord W. G., Klinman D. M., Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation Journal of Immunology 2008 180 11 7648 7654
100. Shirota H., Gursel I., Gursel M., Klinman D. M., Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock Journal of Immunology 2005 174 8 4579 4583
101. Hanakahi L. A., Sun H., Maizels N., High affinity interactions of nucleolin with G-G-paired rDNA Journal of Biological Chemistry 1999 274 22 15908 15912
102. Bianchi A., De Lange T., Ku binds telomeric DNA in vitro Journal of Biological Chemistry 1999 274 30 21223 21227
103. Plitas G., Burt B. M., Nguyen H. M., Bamboat Z. M., DeMatteo R. P., Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis Journal of Experimental Medicine 2008 205 6 1277 1283
104. Barrat F. J., Meeker T., Chan J. H., Guiducci C., Coffmann R. L., Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms European Journal of Immunology 2007 37 12 3582 3586
105. Lian Z.-X., Kikuchi K., Yang G.-X., Ansari A. A., Ikehara S., Gershwin M. E., Expansion of bone marrow IFN-alpha-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-alpha in NZB bone marrow Journal of Immunology 2004 173 8 5283 5289
106. Santiago-Raber M.-L., Baccala R., Haraldsson K. M., Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice Journal of Experimental Medicine 2003 197 6 777 788
107. Vollmer J., Tluk S., Schmitz C., Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 Journal of Experimental Medicine 2005 202 11 1575 1585
108. Jurk M., Kritzler A., Schulte B., Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides European Journal of Immunology 2006 36 7 1815 1826
109. Gorden K. K. B., Qiu X., Battiste J. J. L., Wightman P. P. D., Vasilakos J. P., Alkan S. S., Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines Journal of Immunology 2006 177 11 8164 8170
110. Gursel M., Gursel I., Mostowski H. S., Klinman D. M., CXCL16 influences the nature and specificity of CpG-induced immune activation Journal of Immunology 2006 177 3 1575 1580
111. Trieu A., Roberts T. L., Dunn J. A., Sweet M. J., Stacey K. J., DNA motifs suppressing TLR9 responses Critical Reviews in Immunology 2006 26 6 527 544
112. Park B., Brinkmann M. M., Spooner E., Lee C. C., Kim Y.-M., Ploegh H. L., Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9 Nature Immunology 2008 9 12 1407 1414
113. Pawar R. D., Ramanjaneyulu A., Kulkarni O. P., Lech M., Segerer S., Anders H.-J., Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus Journal of the American Society of Nephrology 2007 18 6 1721 1731